on May 29,2018
QUEBEC CITY, May 29, 2018 - Feldan Therapeutics, Inc. announced today the issuance of a new patent related to the refinement of the Feldan Shuttle platform. This technology, a peptide-based …
Read Storyon May 1,2018
Feldan Therapeutics’ Research Director, Dr. David Guay, will be attending TIDES: Oligonucleotides and Peptide Therapeutics Conference next week, May 7-10th at Hynes Convention Center in Boston. Come to chat with …
Read Story
2666, Boul. du Parc Technologique, Suite 290
Quebec, Qc, Canada,
G1P 4S6
Phone: 1-418-872-7277
Email: info@feldan.com